Orphazyme A/S Common Stock

As of the most recent data (June 2026), ORPHA.CO shows a common stock of $6.3M. That compares with $6.3M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORPHA.CO's common stock is now $6.3M (was $6.3M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Orphazyme A/S is outperforming or lagging.

Tracking ORPHA.CO's common stock over time shows whether Orphazyme A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $6.3M That compares with $6.3M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Orphazyme A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $6.3M) with ownership activity and broader fundamentals.

Orphazyme A/S's common stock is $6.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.